Department of Pharmacology and.
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY.
Blood Adv. 2018 Jan 5;2(1):61-68. doi: 10.1182/bloodadvances.2017012690. eCollection 2018 Jan 9.
Hereditary folate malabsorption (HFM) is an autosomal recessive disorder characterized by impaired intestinal folate absorption and impaired folate transport across the choroid plexus due to loss of function of the proton-coupled folate transporter (PCFT-SLC46A1). We report a novel mutation, causing HFM, affecting a residue located in the 11th transmembrane helix within the external gate. The mutant N411K-PCFT was stable, trafficked to the cell membrane, and had sufficient residual activity to characterize the transport defect and the structural requirements at this site for gate function. The influx V of the N411K mutant was markedly decreased, as was the affinity for most, but not all, folate/antifolate substrates. The greatest loss of activity was for 5-methyltetrahydrofolate. Substitutions with positive charged residues resulted in a loss of activity (arginine > lysine > histidine). Function was retained for the negative charged aspartate, but not the larger glutamate substitutions, whereas the bulky hydrophobic (leucine), or polar (glutamine) substitutions, were tolerated. Homology models of PCFT, in the inward and outward open conformations, based upon the mammalian Glut5 fructose transporter structures, localize Asn411 protruding into the aqueous pathway. This is most prominent when the carrier is in the inward open conformation when the external gate is closed. Mutations at this site likely result in highly specific steric and electrostatic interactions between the Asn411-substituted, and other, residues in the gate region that impede carrier function. The substrate specificity of the N411K mutant may be due to alterations of substrate flows through the external gate, downstream allosteric alterations in the folate-binding pocket, or both.
遗传性叶酸吸收不良(Hereditary folate malabsorption,HFM)是一种常染色体隐性遗传病,其特征为肠道叶酸吸收受损以及脉络丛叶酸转运功能障碍,这是由于质子偶联叶酸转运蛋白(proton-coupled folate transporter,PCFT-SLC46A1)功能丧失所致。我们报道了一种新的突变,导致 HFM,影响位于外部门控的第 11 个跨膜螺旋内的残基。突变体 N411K-PCFT 稳定,能够转运至细胞膜,并且具有足够的残留活性来表征该部位的转运缺陷和结构要求,以实现门控功能。N411K 突变体的流入 V 显著降低,大多数但不是所有叶酸/抗叶酸底物的亲和力也是如此。活性降低最大的是 5-甲基四氢叶酸。带正电荷残基的取代导致活性丧失(精氨酸>赖氨酸>组氨酸)。带负电荷的天冬氨酸取代保留了功能,但较大的谷氨酸取代则不行,而较大的疏水性(亮氨酸)或极性(谷氨酰胺)取代则可以。基于哺乳动物 Glut5 果糖转运蛋白结构的 PCFT 内向和外向开放构象的同源模型,将 Asn411 定位为突出到水相途径中。当载体处于内向开放构象且外部门关闭时,这种情况最为明显。该位点的突变可能导致门控区域中 Asn411 取代的和其他残基之间的高度特异性空间和静电相互作用,从而阻碍载体功能。N411K 突变体的底物特异性可能是由于改变了底物通过外部门的流动,或者改变了叶酸结合口袋中的下游变构,或者两者兼有。